<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent evidence suggests that <z:mp ids='MP_0001845'>inflammation</z:mp> in the central <z:mp ids='MP_0008912'>nervous</z:mp> system plays an important role in the pathogenesis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the identity of the <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, cytokines, and reactive oxygen species, that orchestrate cell <z:hpo ids='HP_0011420'>death</z:hpo> and plaque biogenesis in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, have yet to be elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>We have identified a novel inflammatory mediator, CAP37 (Cationic Antimicrobial Protein <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Mi</z:e> 37 kDa), that promotes mononuclear cell chemotaxis, <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of monocytes to endothelium, and release of oxygen radicals from monocytes </plain></SENT>
<SENT sid="3" pm="."><plain>In the present immunocytochemical study, we demonstrate the expression of CAP37 in the cerebral microvasculature in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>CAP37 was not detected in brain vessels of <z:mpath ids='MPATH_458'>normal</z:mpath> controls or patients with other neuropathologic conditions such as Pick's, Parkinson's, <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger's disease</z:e>, <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">Progressive Supranuclear Palsy</z:e>, and <z:e sem="disease" ids="C0006840" disease_type="Disease or Syndrome" abbrv="">Candida infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment of cerebral endothelial cultures with <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, cytokines or beta-amyloid results in the induction of CAP37 expression </plain></SENT>
<SENT sid="6" pm="."><plain>These in vitro data showing endothelial-CAP37 expression after beta-amyloid treatment together with the previous demonstration that CAP37 stimulates mononuclear cell migration and activation, suggest that CAP37 could contribute to neuronal injury in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>